GlassScriptPhysician profile
Eric Adam Breitbart
NPI 1932334562
$3,620.00
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $153 · 2021: $781 · 2022: $2,154 · 2024: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,905.93 | 2019-2024 | Comprehensive Shoulder System, Avenir, Rosa |
| Pacira Therapeutics, INC. | $347.13 | 2019-2021 | |
| Djo, LLC | $70.45 | 2019-2021 | |
| Ermi LLC | $44.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.80 | 2020-2021 | |
| Allergan, INC. | $34.11 | 2021-2022 | |
| Si-Bone, INC. | $28.84 | 2022 | |
| Electronic Waveform Lab, INC. | $25.61 | 2019 | |
| Orthalign INC | $22.37 | 2024 | Orthalign Plus |
| Smith+Nephew, INC. | $21.15 | 2021 | |
| Orthofix Medical, INC. | $18.77 | 2019 | |
| Radius Health, INC. | $14.45 | 2021 | |
| Endo Pharmaceuticals INC. | $14.33 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $14.18 | 2021 | |
| Davol INC. | $11.76 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $9.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Breitbart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.